| ·           | Revenue      of $6.9 million, an increase of 66% year-over-year from Q1    08 |
|--------------------------------------------------------------------|-------------------------------------------------------------------------------|

| ·           | 16.8%      sequential increase in revenues from Q408 |
|--------------------------------------------------------------------|------------------------------------------------------|

| ·           | 55.3%      gross margin up from 53.1% in Q4 08 |
|--------------------------------------------------------------------|------------------------------------------------|

| ·                | 9.8%      sequential increase in Avg. Revenue/Requisition to $900 from $820 in Q4      08 |
|--------------------------------------------------------------------|-------------------------------------------------------------------------------------------|

| ·                | 6.0%      sequential increase in Avg. Revenue/Test to $661 from $624 in Q4      08 |
|--------------------------------------------------------------------|------------------------------------------------------------------------------------|

| ·                | SG&A      expenses declined to 53.2% of revenue from 56.1% in Q4  08 |
|--------------------------------------------------------------------|--------------------------------------------------------------------------|

----

----

| NeoGenomics,      Inc.              | The      Investor Relations Group   |
|-------------------------------------|-------------------------------------|
| Steven      C. Jones                | Investor      Relations:            |
| Director      of Investor Relations | Rachel      Colgate                 |
| (239)      325-2001                 | (212)      825-3210                 |
| sjones@neogenomics.org              | rcolgate@investorrelationsgroup.com |
|                                | or                                  |
| Hawk      Associates, Inc.          | Media      Relations:               |
| Ms.      Julie Marshall             | Janet      Vasquez                  |
| (305)-451-1888                      | (212)      825-3210                 |
| neogenomics@hawkassociates.com      | jvasquez@investorrelationsgroup.com |

----

|                                                                                                                                |   |                |      |   |                   |   |
|-------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------|-----------|--------|------------------------|--------|
| ASSETS                                                                                                                              |   | March      31, 2009 |      |   | December      31, 2008 |   |
|                                                                                                                                |   |                |      |   |                   |   |
|   Cash      and cash equivalents                                                                                          |   | $                   | 857,190   |   |                   | $      | 468,171 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
|   Accounts      Receivable (net of allowance for      doubtful accounts of $474,337 and      $358,642, respectively) |   |                | 3,955,266 |   |                   |   | 2,913,531 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
|   Other      Current Assets                                                                                               |   |                | 1,074,888 |   |                   |   | 973,867 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| TOTAL      CURRENT ASSETS                                                                                                           |   |                | 5,887,344 |   |                   |   | 4,355,569 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| PROPERTY AND EQUIPMENT      (net of accumulated      depreciation of $1,839,653 and $1,602,594, respectively)                       |   |                | 2,857,025 |   |                   |   | 2,875,297 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| OTHER      ASSETS                                                                                                                   |   |                | 72,791    |   |                   |   | 64,509 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
|     TOTAL                                                                                                       |   | $                   | 8,817,160 |   |                   | $      | 7,295,375 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| LIABILITIES      AND STOCKHOLDERS’ EQUITY                                                                                     |   |                |      |   |                   |   |   |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| CURRENT      LIABILITIES                                                                                                            |   | $                   | 5,152,506 |   |                   | $      | 4,390,995 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| LONG      TERM LIABILITIES                                                                                                          |   |                | 1,371,334 |   |                   |   | 1,403,271 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
|     TOTAL      LIABILITIES                                                                                      |   |                | 6,523,840 |   |                   |   | 5,794,266 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
| STOCKHOLDERS’      EQUITY                                                                                                     |   |                | 2,293,320 |   |                   |   | 1,501,109 |   |
|                                                                                                                                |   |                |      |   |                   |   |   |   |
|    TOTAL                                                                                                             |   | $                   | 8,817,160 |   |                   | $      | 7,295,375 |   |

----

|                                                                     |   |                                              |       |   |                                      |   |
|--------------------------------------------------------------------------|--------|---------------------------------------------------|------------|--------|-------------------------------------------|--------|
|                                                                     |   | For theThree-MonthsEnded March 31,      2009 |       |   | For theThree-MonthsEndedMarch 31,    2008 |   |
|                                                                     |   |                                              |       |   |                                      |   |
| REVENUE                                                                  |   | $                                                 | 6,913,520  |   |                                      | $      | 4,162,762 |   |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| COST      OF REVENUE                                                     |   |                                              | 3,090,442  |   |                                      |   | 1,858,474 |   |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| GROSS      PROFIT                                                        |   |                                              | 3,823,078  |   |                                      |   | 2,304,288 |   |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| OPERATING EXPENSES -                                                     |   |                                              |       |   |                                      |   |   |   |
| Selling, general and      administrative                                 |   |                                              | 3,675,084  |   |                                      |   | 2,514,555 |   |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| Income (loss) from      operations                                       |   |                                              | 147,994    |   |                                      |   | (210,267 | ) |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| Other income (loss)      -                                               |   |                                              |       |   |                                      |   |   |   |
| Interest income/(expense), net                                           |   |                                              | (114,816   | )      |                                      |   | (55,096 | ) |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| NET INCOME      (LOSS)                                                   |   | $                                                 | 33,178     |   |                                      | $      | (265,363 | ) |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| NET INCOME (LOSS) PER      SHARE                                         |   |                                              |       |   |                                      |   |   |   |
| - Basic                                                                  |   | $                                                 | 0.00       |   |                                      | $      | (0.01 | ) |
| - Diluted                                                                |   | $                                                 | 0.00       |   |                                      | $      | (0.01 | ) |
|                                                                     |   |                                              |       |   |                                      |   |   |   |
| WEIGHTED AVERAGE      NUMBER   OF SHARES      OUTSTANDING |   |                                              |       |   |                                      |   |   |   |
| - Basic                                                                  |   |                                              | 32,173,698 |   |                                      |   | 31,400,947 |   |
| - Diluted                                                                |   |                                              | 35,630,058 |   |                                      |   | 31,400,947 |   |

----

|  NeoGenomics,      Inc. |
|------------------------------|

|                                                                                   |   |  For theThree-Months EndedMarch 31,    2009 |     |   | For theThree-Months EndedMarch 31,    2008 |   |
|----------------------------------------------------------------------------------------|--------|--------------------------------------------------|----------|--------|--------------------------------------------|--------|
|                                                                                   |   |                                             |     |   |                                       |   |
| NET      CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES                               |   | $                                                | (331,538 | )      |                                       | $      | 194,638 |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| NET      CASH USED IN INVESTING ACTIVITIES                                             |   |                                             | (5,886   | )      |                                       |   | (25,115 | ) |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| NET      CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES                               |   |                                             | 726,443  |   |                                       |   | (49,738 | ) |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| NET INCREASE  IN      CASH AND CASH EQUIVALENTS                              |   |                                             | 389,019  |   |                                       |   | 119,785 |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| CASH      AND CASH EQUIVALENTS, BEGINNING OF PERIOD                                    |   |                                             | 468,171  |   |                                       |   | 210,573 |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| CASH      AND CASH EQUIVALENTS, END OF PERIOD                                          |   | $                                                | 857,190  |   |                                       | $      | 330,358 |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| SUPPLEMENTAL      DISCLOSURE OF CASH FLOW INFORMATION:                                 |   |                                             |     |   |                                       |   |   |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| Interest      paid                                                                     |   | $                                                | 100,391  |   |                                       | $      | 47,931 |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| Income      taxes paid                                                                 |   | $                                                | -        |   |                                       | $      | - |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| SUPPLEMENTAL      DISCLOSURE OF NON-CASH INVESTING AND FINANCING      ACTIVITIES: |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| Equipment      leased under capital lease                                              |   | $                                                | 178,837  |   |                                       | $      | 162,043 |   |
|                                                                                   |   |                                             |     |   |                                       |   |   |   |
| Equipment      purchased and included in accounts payable at March 31,    2008         |   |                                             | 46,250   |   |                                       |   | 33,713 |   |

----

|                                  |   |                                             |      |   |                                              |   |      |                          |   |
|---------------------------------------|--------|--------------------------------------------------|-----------|--------|---------------------------------------------------|--------|-----------|-------------------------------|--------|
|                                  |   | For      theThree-MonthsEndedMarch      31, 2009 |      |   | For the Three-MonthsEndedMarch      31, 2008 |   |      |    % Inc (Dec) |   |
|                                  |   |                                             |      |   |                                              |   |      |                          |   |
| Requisitions      Rec’d (Cases) |   |                                             | 7,681     |   |                                              |   | 5,405     |                          |   |   | 42.1% |   |
| #      of Tests Performed             |   |                                             | 10,457    |   |                                              |   | 6,759     |                          |   |   | 54.7% |   |
| Avg.      # of Tests / Case           |   |                                             | 1.36      |   |                                              |   | 1.25      |                          |   |   | 8.8% |   |
|                                  |   |                                             |      |   |                                              |   |      |                          |   |   |   |   |
| Testing      Revenue                  |   | $                                                | 6,913,520 |   |                                              | $      | 4,162,762 |                          |   |   | 66.1% |   |
| Avg      Revenue/Requisition          |   | $                                                | 900.08    |   |                                              | $      | 770.17    |                          |   |   | 16.9% |   |
| Avg      Revenue/Test                 |   | $                                                | 661.14    |   |                                              | $      | 615.88    |                          |   |   | 7.3% |   |

----